Locatie (venue) Symposium: Auditorium van de Vrije Universiteit De Boelelaan 1105, Amsterdam This scientific symposium is organized by the Department of Medical Oncology, VU University Medical Center and is of interest to medical doctors (in training), nurses, and persons involved in laboratory research. The topics presented will give an elegant overview of the opportunities and challenges in the diagnosis and treatment of breast cancer, with emphasis on novel developments. Routebeschrijving: (itinerary) http://www.vu.nl/nl/over-de-vu/contact-routebeschrijving/index.asp Parkeergarage (parking) http://www.vumc.nl/afdelingen/over-vumc/route-contact/203683/ Inschrijving (registration) Deelname is gratis (free of charge). In verband met de voorbereidingen voor lunch en/of accreditatie gaarne aanmelden via e-mail: [email protected] (mevr. Maartje Klaassen, secretaresse prof.dr. E. Boven) Accreditatie Nederlandse Internisten Vereniging (NIV): 3 punten Let op: om in aanmerking te komen voor een certificaat dient u bij aanmelding uw BIG-nummer op te geven. Afscheidsrede Aula van de Vrije Universiteit (valedictory address) Kadotip o.v.v. ‘afscheid prof. Boven’ NL69ABNLA0445040459 ten name van Stichting VUmc CCA, ter ondersteuning van de lifestyle polikliniek (http://www.vumc.nl/afdelingen/CCA/) òf NL50INGB0000500222 ten name van Friends Indeed, Amsterdam, ter ondersteuning van een scholenproject aan de arme oostkust van India (www.friendsindeed.nl) Uitnodiging Symposium woensdag 30 april, 2014 Breast cancer, opportunities and challenges Voorafgaand aan de afscheidsrede (valedictory address) Prof.dr. Epie Boven Program 10.30- 11.00 Registration & Coffee/Tea: Foyer Auditorium 12.45- 13.40 Part I Chairman Prof.dr. Elsken van der Wall Department of Medical Oncology, University Medical Center Utrecht and chairman of the Dutch Breast Cancer Research Group Part II Chairman Dr. Inge R.H.M. Konings Department of Medical Oncology, VU University Medical Center 11.00- 11.05 Welcome & Opening 13.45- 14.00 Molecular imaging of ER in advanced breast cancer patients Prof.dr. Geke A.P. Hospers Department of Medical Oncology, University Medical Center Groningen 14.05- 14.25 Inhibitors of PI3K-AKT-mTOR or CDK4/6 or genomic drug selection? Dr. Monica Arnedos Breast Cancer Unit, Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France 11.05- 11.20 Women with a CHEK-2 mutation: breast cancer risk Dr. Muriel A. Adank Department of Clinical Genetics, VU University Medical Center 11.25- 11.40 Experimental BRCA deficiency: usefulness and hurdles Prof.dr. J. Jonkers Department of Molecular Oncology, Netherlands Cancer Institute 11.45- 12.00 Genomic BRCA-like classification and clinical relevance Prof.dr. Sabine C. Linn Department of Molecular Biology and Medical Oncology, Netherlands Cancer Institute 12.05- 12.20 Breast cancer angiogenesis from another angle: galectins Prof.dr. Arjan W. Griffioen Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center 12.25- 12.40 Immunophenotyping of breast cancer metastases: paving the road for molecular imaging Prof.dr. Paul J. van Diest Department of Pathology, University Medical Center Utrecht Lunch 14.30- 14.45 Psychosocial care for patients with advanced cancer Prof.dr. Joost Dekker Department of Psychiatry, VU University Medical Center 14.50- 15.00 Future of the Dutch Breast Cancer Research Group Prof.dr. Elsken van der Wall Chairman of the Dutch Breast Cancer Research Group 15.00- 15.30 Tea/Coffee: Foyer Aula VU University 15.45- 16.30 Afscheidsrede (valedictory address) Leven voor de patiënt Aula VU University (main building) 16.40 Reception